Tesamorelin 10mg
Synthetic GHRH analogue studied for pituitary receptor signaling, growth hormone regulation, and endocrine pathway research.
Compound Overview
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied in laboratory environments for its interaction with pituitary GHRH receptors and downstream endocrine signaling pathways. As a modified peptide analogue, it is commonly evaluated in research systems focused on growth hormone regulation and peptide-mediated hormonal communication.
In experimental models, Tesamorelin is frequently studied for receptor-binding activity, pulsatile growth hormone signaling dynamics, and downstream pathway interactions involving endocrine feedback systems. Research often examines its role in pituitary communication networks, IGF-related signaling pathways, and hormone-regulated metabolic processes under controlled laboratory conditions.
Pituitary Signaling Research
Studied for activation of GHRH receptors involved in pituitary communication and growth hormone pathway signaling.
Endocrine Pathway Studies
Frequently evaluated in laboratory models examining GH regulation, IGF-related signaling, and hormonal feedback systems.
Laboratory Classification
Classified as a synthetic GHRH analogue for experimental and analytical endocrine research applications.
Product Specifications
- Product Name: Tesamorelin
- Peptide Type: Synthetic GHRH analogue
- Quantity: 10mg per vial
- Form: Lyophilized peptide powder
- Research Focus: Pituitary and growth hormone pathway signaling
- Intended Use: Research use only









Reviews
There are no reviews yet.